News >

Immunotherapy Begins New Therapeutic Path in Metastatic TNBC

Jessica Hergert
Published: Wednesday, Sep 25, 2019

Jeremy M. Force, DO, medical oncologist and assistant professor of medicine at Duke University School of Medicine

Jeremy M. Force, DO

Ever-expanding immunotherapeutic and other novel approaches could signal a change in treatment for patients with metastatic triple-negative breast cancer (TNBC), said Jeremy M. Force, DO.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication